BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30884126)

  • 1. Taiwanin C elicits apoptosis in arecoline and 4-nitroquinoline-1-oxide-induced oral squamous cell carcinoma cells and hinders proliferation via epidermal growth factor receptor/PI3K suppression.
    Tsai CY; Fang HY; Shibu MA; Lin YM; Chou YC; Chen YH; Day CH; Shen CY; Ban B; Huang CY
    Environ Toxicol; 2019 Jun; 34(6):760-767. PubMed ID: 30884126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taiwanin C selectively inhibits arecoline and 4-NQO-induced oral cancer cell proliferation via ERK1/2 inactivation.
    Lin KH; Shibu MA; Kuo YH; Chen YC; Hsu HH; Bau DT; Chen MC; Tu CC; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Jan; 32(1):62-69. PubMed ID: 26537528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
    Hsieh CH; Hsu HH; Shibu MA; Day CH; Bau DT; Ho CC; Lin YM; Chen MC; Wang SH; Huang CY
    Mol Carcinog; 2017 Mar; 56(3):1055-1067. PubMed ID: 27648737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taiwanin E Induces Cell Cycle Arrest and Apoptosis in Arecoline/4-NQO-Induced Oral Cancer Cells Through Modulation of the ERK Signaling Pathway.
    Wang SH; Wu HC; Badrealam KF; Kuo YH; Chao YP; Hsu HH; Bau DT; Viswanadha VP; Chen YH; Lio PJ; Chiang CJ; Huang CY
    Front Oncol; 2019; 9():1309. PubMed ID: 31921618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helioxanthin suppresses the cross talk of COX-2/PGE2 and EGFR/ERK pathway to inhibit Arecoline-induced Oral Cancer Cell (T28) proliferation and blocks tumor growth in xenografted nude mice.
    Lin YM; Kuo WW; Velmurugan BK; Hsien HH; Hsieh YL; Hsu HH; Tu CC; Bau DT; Viswanadha VP; Huang CY
    Environ Toxicol; 2016 Dec; 31(12):2045-2056. PubMed ID: 26464283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
    Chang NW; Tsai MH; Lin C; Hsu HT; Chu PY; Yeh CM; Chiu CF; Yeh KT
    Biochim Biophys Acta; 2011 Apr; 1812(4):558-64. PubMed ID: 21081159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taiwanin A targets non-steroidal anti-inflammatory drug-activated gene-1 in human lung carcinoma.
    Harn HJ; Chuang HM; Chang LF; Huang AY; Hsieh ST; Lin SZ; Chou CW; Kuo YH; Chiou TW
    Fitoterapia; 2014 Dec; 99():227-35. PubMed ID: 25173462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
    Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
    Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways.
    Shyur LF; Lee SH; Chang ST; Lo CP; Kuo YH; Wang SY
    Phytomedicine; 2010 Dec; 18(1):16-24. PubMed ID: 20637573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taiwanin E inhibits cell migration in human LoVo colon cancer cells by suppressing MMP-2/9 expression via p38 MAPK pathway.
    Hsu HH; Kuo WW; Day CH; Shibu MA; Li SY; Chang SH; Shih HN; Chen RJ; Viswanadha VP; Kuo YH; Huang CY
    Environ Toxicol; 2017 Aug; 32(8):2021-2031. PubMed ID: 27807932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taiwanin A induced cell cycle arrest and p53-dependent apoptosis in human hepatocellular carcinoma HepG2 cells.
    Ho PJ; Chou CK; Kuo YH; Tu LC; Yeh SF
    Life Sci; 2007 Jan; 80(5):493-503. PubMed ID: 17182066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of extractives from Taiwania cryptomerioides heartwood.
    Chang ST; Wang DS; Wu CL; Shiah SG; Kuo YH; Chang CJ
    Phytochemistry; 2000 Oct; 55(3):227-32. PubMed ID: 11142847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
    Qiu Y; Li C; Wang Q; Zeng X; Ji P
    Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
    Chuerduangphui J; Ekalaksananan T; Chaiyarit P; Patarapadungkit N; Chotiyano A; Kongyingyoes B; Promthet S; Pientong C
    PLoS One; 2018; 13(1):e0192009. PubMed ID: 29385191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L
    Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft.
    Cho JH; Lee RH; Jeon YJ; Shin JC; Park SM; Choi NJ; Seo KS; Yoon G; Cho SS; Kim KH; Cho JJ; Cho YS; Kim DH; Hong JT; Lee TH; Park HJ; Jung S; Seo JM; Chen H; Dong Z; Chae JI; Shim JH
    Int J Biochem Cell Biol; 2015 Jul; 64():287-97. PubMed ID: 25982202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.